A number of approaches are currently being examined to lessen the effect of the condition such as the development of transgenic vegetation to create hypoallergenic peanuts, but Professor Burks says as many peanut proteins get excited about the allergic response, the resulting product is actually a peanut which is no a peanut longer. Professor Burks says future treatments are all concentrated around curbing the immune response or inducing the immune system to tolerate a particular food allergen, possibly by introducing built peanut proteins as immunotherapy, where the food is ingested in progressively larger amounts on a regular basis.Tuberculosis is a leading reason behind death worldwide, and 8 nearly. 8 million cases of TB happen each full year, in middle-income and low-income countries mostly. Today, laboratory-based technologies supply the primary opportinity for diagnosing the condition, but these technologies often fail to identify large numbers of active cases, take weeks to provide results, lack crucial drug resistance information, or cannot meet the needs of people with limited usage of lab facilities. Alere's collaboration with the Gates Foundation will produce a sensitive highly, low-cost diagnostic that can be implemented in lower-level laboratories or beyond your lab altogether.